Literature DB >> 14715111

Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis.

Yu Koyama1, Kouji Kaneko, Kohei Akazawa, Chizuko Kanbayashi, Tatsuo Kanda, Katsuyoshi Hatakeyama.   

Abstract

Lymph node metastasis is a major prognostic factor for patients with breast cancer. Vascular endothelial growth factors (VEGF)-C and VEGF-D are capable of stimulating lymphangiogenesis, and VEGF-C enhances lymphatic metastasis. The aim of the present study was to determine whether VEGF-C and VEGF-D messenger RNA (mRNA) expression is correlated with lymphatic invasion and lymph node metastasis in patients with breast cancer. Total RNAs were isolated from 33 surgical specimens of breast cancer tissue and 7 samples of normal breast tissue. VEGF-C and VEGF-D mRNA expression was measured by quantitative reverse transcription-polymerase chain reaction analysis. There was no correlation between VEGF-C mRNA expression and lymphatic invasion or lymph node metastasis. However, VEGF-D mRNA expression was decreased in cancer tissue, and it was inversely correlated with lymphatic invasion and the number of metastatic lymph nodes. An increased VEGF-C/VEGF-D ratio was also correlated with lymph node metastasis and the number of metastatic lymph nodes. Our results suggest that a decrease in VEGF-D mRNA or an increase in the VEGF-C/VEGF-D ratio may have an association with tumorigenesis and/or lymph node metastasis in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715111     DOI: 10.3816/cbc.2003.n.041

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  19 in total

1.  Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

Authors:  S J Grau; F Trillsch; J Herms; N Thon; P J Nelson; J-C Tonn; R Goldbrunner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

Review 2.  Lymphangiogenesis and lymphatic vessel remodelling in cancer.

Authors:  Steven A Stacker; Steven P Williams; Tara Karnezis; Ramin Shayan; Stephen B Fox; Marc G Achen
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

Review 3.  Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.

Authors:  Jun Wang; Yan Guo; Baocheng Wang; Jingwang Bi; Kainan Li; Xiuju Liang; Huili Chu; Huihui Jiang
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

4.  Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.

Authors:  Yutaka Yonemura; Yoshio Endo; Kayoko Tabata; Taiichi Kawamura; Hyo-Yung Yun; Etsurou Bandou; Takuma Sasaki; Masahiro Miura
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

5.  Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells.

Authors:  Luana Schito; Sergio Rey; Marco Tafani; Huafeng Zhang; Carmen Chak-Lui Wong; Andrea Russo; Matteo A Russo; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 6.  Non-angiogenic functions of VEGF in breast cancer.

Authors:  Arthur M Mercurio; Elizabeth A Lipscomb; Robin E Bachelder
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

7.  Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer.

Authors:  Yi-Tao Jia; Zhong-Xin Li; Yu-Tong He; Wei Liang; Hui-Chai Yang; Hong-Jun Ma
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 8.  Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms.

Authors:  Suzanne Eccles; Lenaic Paon; Jonathan Sleeman
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

Review 9.  Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2012-12-10       Impact factor: 9.867

10.  Bosentan protects the spinal cord from ischemia reperfusion injury in rats through vascular endothelial growth factor receptors.

Authors:  S Gong; Z Seng; W Wang; J Lv; Q Dong; B Yan; L Peng; X He
Journal:  Spinal Cord       Date:  2014-09-02       Impact factor: 2.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.